Editorials

Beyond venetoclax and azacitidine: CD70-targeted triplet therapy in acute myeloid leukemia

Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille
Haematologica Early view Oct 1, 2026 https://doi.org/10.3324/haematol.2026.302012